Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

692
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
692
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

270
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
270

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel Cellular Signalling Axes in Neurodegenerative Diseases: From NLRP3 Inflammasome to Wnt/β-Catenin and Hippo-YAP Pathways.

Journal of biochemical and molecular toxicology·2026
Same author

Thermo-Sensitive Polymeric Networks for Next-Generation Wound Management: A Review.

AAPS PharmSciTech·2026
Same author

Repurposing Imeglimin for Chemotherapy-Induced Cognitive Impairment: Targeting Mitochondrial Dysfunction and Neuroinflammation.

Cellular and molecular neurobiology·2026
Same author

Smart Stings of Nature: Harnessing Microneedles Assisted Targeted Phytoconstituent Delivery for Dermatological Disorders.

AAPS PharmSciTech·2026
Same author

Crocetin as a Neuroprotective Agent: Targeting Western Diet-Induced Cognitive Dysfunction Through Antioxidant, Anti-Inflammatory and Gut-Brain Axis Modulation.

ASN neuro·2025
Same author

Next-generation microneedle platforms for site-specific management of diabetic neuropathy.

Diabetology & metabolic syndrome·2025
Same journal

Correction to "Mathematical Modelling of COVID-19 Transmission in Kenya: A Model with Reinfection Transmission Mechanism".

Computational and mathematical methods in medicine·2025
Same journal

RETRACTION: Ligustrazine Inhibits Lung Phosphodiesterase Activity in a Rat Model of Allergic Asthma.

Computational and mathematical methods in medicine·2025
Same journal

RETRACTION: Delivery of miR-224-5p by Exosomes from Cancer-Associated Fibroblasts Potentiates Progression of Clear Cell Renal Cell Carcinoma.

Computational and mathematical methods in medicine·2025
Same journal

RETRACTION: Empirical Analysis of the Nursing Effect of Intelligent Medical Internet of Things in Postoperative Osteoarthritis.

Computational and mathematical methods in medicine·2025
Same journal

RETRACTION: Evaluation and Analysis of the Intervention Effect of Systematic Parent Training Based on Computational Intelligence on Child Autism.

Computational and mathematical methods in medicine·2024
Same journal

RETRACTION: Humanistic Spirit Training of Medical Students Based on Multisource Medical Data Fusion.

Computational and mathematical methods in medicine·2024
See all related articles

Related Experiment Video

Updated: Sep 21, 2025

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

8.0K

Supervised Computer-Aided Diagnosis (CAD) Methods for Classifying Alzheimer's Disease-Based Neurodegenerative

Suneet Gupta1, V Saravanan2, Amarendranath Choudhury3

  • 1Dept. of CSE, School of Engineering and Technology, Mody University, Lakshmangarh, Rajasthan 332311, India.

Computational and Mathematical Methods in Medicine
|June 2, 2022
PubMed
Summary
This summary is machine-generated.

This study introduces a machine learning approach using 3D MRI data for Alzheimer's disease (AD) diagnosis. The method significantly improves classification accuracy and reduces diagnosis time compared to traditional techniques.

More Related Videos

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

375
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K

Related Experiment Videos

Last Updated: Sep 21, 2025

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

8.0K
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

375
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K

Area of Science:

  • Medical Imaging
  • Machine Learning
  • Neurology

Background:

  • Alzheimer's disease (AD) diagnosis is crucial for timely treatment, but manual methods are time-consuming and expensive.
  • Machine learning offers a potential solution to expedite and improve diagnostic processes.

Purpose of the Study:

  • To develop and evaluate a machine learning transfer learning method for Alzheimer's disease diagnosis using 3D MRI data.
  • To reduce the time and computational cost associated with AD diagnosis.

Main Methods:

  • A transfer learning approach utilizing a M-Net migration network to extract bottleneck features from 3D MRI data.
  • Supervised training with an added top layer for dimensionality reduction and classification.
  • Combining subject slice properties for final classification of AD symptoms and controls.

Main Results:

  • The proposed transfer network demonstrated improved computational efficiency and reduced training time.
  • Achieved 1.5 percentage points higher classification accuracy compared to using VGG16 alone for feature extraction.
  • Showcased an 8% improvement in classification accuracy and a 60-fold reduction in training time compared to typical transfer learning networks, using OASIS dataset.

Conclusions:

  • The developed transfer learning method offers significant advantages in terms of speed and accuracy for Alzheimer's disease diagnosis.
  • This approach can effectively aid in the early and efficient diagnosis of Alzheimer's disease.
  • The method shows promise for clinical application in reducing diagnostic burden.